
5 Jul 2026
Weight Loss Injections Cost in Ireland 2026: Mounjaro, Wegovy and Saxenda Compared
All medical information is reviewed by our clinical partners at MedicOnline.
Dr. Jahan Khan, CMO @ MedicOnline
IMC 409788
If you have been researching weight loss injections in Ireland, you have probably found plenty of information about how they work and who qualifies. What is harder to find is a straight answer about what they actually cost.
That is what this guide is for. We break down the real cost of the main treatments available in Ireland, explain what is and is not covered by the State, and show you how to reduce your annual spend by up to 20% through tax relief.
If you are still deciding which medication might suit you, start with our clinical comparison of Wegovy vs Mounjaro in Ireland. This guide focuses purely on the money.
Why Prices Vary So Much
There is no single price for any of these medications in Ireland. Three things determine what you actually pay each month:
The medication itself. Each drug has a different wholesale cost set by the manufacturer. Mounjaro and Wegovy are priced differently, and Saxenda sits in its own bracket.
The dose you are on. Mounjaro in particular gets more expensive as your dose increases. Wegovy pricing is more consistent across the dose range.
Which pharmacy you use. Pharmacies set their own dispensing margins. The same pen can cost meaningfully different amounts at two pharmacies on the same street. This is why shopping around - or using a service with negotiated pricing - matters.
What Each Medication Costs at the Pharmacy
The table below shows indicative monthly medication costs across the three licensed weight loss treatments in Ireland. These are pharmacy costs only and do not include any consultation or programme fee.
Mounjaro (tirzepatide)
€200 - €600 (varies by dose)
Once-weekly injection · Weight management and type 2 diabetes
Wegovy (semaglutide)
€170 - €250
Once-weekly injection · Weight management
Saxenda (liraglutide)
€280 - €320
Once-daily injection · Weight management
Prices are indicative and vary by pharmacy. Always confirm with your pharmacy before ordering.
Bua's Partner Pharmacy Pricing: Bua Health has negotiated the lowest fixed pricing through our partner pharmacy network. When you join the programme, your prescription can be sent to our partner pharmacy for fixed, predictable rates at every dose level. You always have the option to use any pharmacy in Ireland.
A note on Saxenda: Bua Health offers Mounjaro and Wegovy as treatment options. Saxenda (liraglutide) is included in this comparison for context, as it is the third licensed weight loss injection in Ireland. It requires a daily injection rather than weekly, and clinical trials showed lower average weight loss compared to both Mounjaro and Wegovy. It is the only weight loss medication currently eligible for partial HSE reimbursement (under strict criteria).
Mounjaro: Cost by Dose
Mounjaro has the widest price range of the three because the cost scales with the dose. You start at 2.5mg and titrate upward over several months. Not everyone needs to reach the highest doses - your doctor will find the level where you are getting good results with manageable side effects.
2.5mg - Starting dose (weeks 1-4)
From €200
5mg - Early titration (weeks 5-8)
€250 - €350
7.5mg - Mid titration (weeks 9-12)
€300 - €400
10mg - Later titration
€350 - €475
12.5mg - Higher dose
€400 - €525
15mg - Maximum maintenance
Up to €600
Eli Lilly increased the list price in September 2025, so older figures you may have seen elsewhere are out of date.
Mounjaro showed the highest average weight loss of the three medications in clinical trials - up to 22.5% of body weight in the SURMOUNT-1 study. For more detail on what to expect from the medication, see our post on what weight loss injections are available in Ireland. For side effects at each dose, see our guide to Mounjaro side effects in Ireland.
Wegovy: Cost Breakdown
Wegovy pricing is more straightforward than Mounjaro. The cost is more consistent across the dose range, making it easier to budget for.
Monthly pharmacy costs in Ireland typically fall between €170 and €250, depending on the dose and pharmacy. Wegovy uses a 16-week titration schedule building from 0.25mg up to the 2.4mg maintenance dose. Costs at the lower titration doses may be at the bottom of this range.
Wegovy became available in Ireland in March 2025. It is the only semaglutide product formally licensed for weight management - Ozempic, which contains the same active ingredient, is licensed for type 2 diabetes only. If you are weighing up these two, our guide to Wegovy eligibility in Ireland explains the differences.
The Other Cost: Clinical Support
The medication price is only half the picture. You also need a doctor to assess you, prescribe, monitor your progress, adjust doses, and manage any side effects. How much that costs depends on the route you take.
Through your GP: A standard GP visit in Ireland costs €50 to €70. During the first few months on treatment, you will likely need monthly appointments for dose changes and safety checks. That is €50-70 per visit, without any dietitian support, without between-visit messaging, and without specialist weight management expertise. Over six months, GP visits alone could total €300-420 - and if you want dietary guidance, a private dietitian referral adds €60-100 per session on top of that.
Through Bua Health: €50 per month, all in. That covers your initial doctor assessment, ongoing monthly reviews, prescription management, specialist dietitian access, and unlimited messaging with the clinical team. No contracts, no auto-renewals. Pay as you go. Full refund if you are found to be ineligible.
The difference is not just price. It is having everything in one place, managed by a team that specialises in medical weight management, rather than piecing together GP visits, pharmacy trips, and separate dietitian appointments.
Tax Relief: Getting 20% Back
Most patients do not realise they can claim back 20% of their total weight loss treatment costs through Revenue. Both your consultation fees and your medication costs qualify for medical expenses tax relief.
Clinical support (€50 x 12 months): €600
Medication (average €300/month x 12): €3,600
Total annual spend: €4,200
Tax relief at 20%: €840 back
You claim through Revenue's myAccount portal or by submitting a Med 1 form. Keep every receipt from your pharmacy and your consultation provider.
For a full step-by-step walkthrough, see our tax relief guide.
Is Any of This Covered by the HSE?
As of mid-2026, the picture is limited:
Saxenda is the only weight loss medication partially reimbursed under State schemes, and only under a strict Managed Access Protocol for patients meeting very specific criteria (BMI 35+, prediabetes, elevated cardiovascular risk).
Mounjaro and Wegovy are not currently reimbursed for weight management. NCPE assessments are ongoing, with decisions expected during 2026. If reimbursement is approved, it would significantly change the cost landscape for Irish patients.
For now, the vast majority of patients pay privately. Tax relief is the most practical way to bring costs down.
So Which One Offers the Best Value?
It depends on what "value" means for your situation.
Wegovy is the most affordable at maintenance doses (€170-250/month) and has strong clinical data behind it, including proven cardiovascular benefits from the SELECT trial.
Mounjaro costs more (€200-600/month depending on dose) but has shown the greatest average weight loss in clinical trials. For some patients, the extra cost may be justified by stronger results.
This is not a decision to make based on price alone. Your doctor will assess your health profile, medical history, and goals to recommend the treatment that is clinically right for you. A prescription is not guaranteed, and eligibility is always determined by an IMC-registered doctor. Cost matters, but clinical suitability matters more.
You can check your eligibility online in under 4 minutes. Our clinical partners at MedicOnline will review your assessment and, if appropriate, recommend the most suitable treatment for your situation. If you are not eligible, you receive a full refund of your programme fee.
References
- Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. NEJM, 387(3), 205-216.
- Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). NEJM, 384(11), 989-1002.
- Pi-Sunyer, X., et al. (2015). A Randomised, Controlled Trial of 3.0mg of Liraglutide in Weight Management. NEJM, 373(1), 11-22.
- European Medicines Agency. Mounjaro, Wegovy, Saxenda EPARs.
- Revenue Commissioners. Medical Expenses Relief (IT 6).
Related Blogs

Who Qualifies for Mounjaro in Ireland?
An overview of the clinical criteria, safety checks, and medical assessment process doctors use to decide who is eligible for Mounjaro® (tirzepatide) in Ireland.
Read
What weight loss injections are available in Ireland?
A clear breakdown of the three main medical treatments for weight management in Ireland in 2025 and 2026
Read
Who can't take Mounjaro? Understanding the contraindications
A comprehensive guide to the absolute contraindications and other cautions that determine who cannot safely take Mounjaro® (tirzepatide) in Ireland.
Read
Who Qualifies for Mounjaro in Ireland?
An overview of the clinical criteria, safety checks, and medical assessment process doctors use to decide who is eligible for Mounjaro® (tirzepatide) in Ireland.

What weight loss injections are available in Ireland?
A clear breakdown of the three main medical treatments for weight management in Ireland in 2025 and 2026

Who can't take Mounjaro? Understanding the contraindications
A comprehensive guide to the absolute contraindications and other cautions that determine who cannot safely take Mounjaro® (tirzepatide) in Ireland.
